About Mark Moehring
Form D filings for OtoNexus Medical Technologies from 2012 to 2024 list Mark Moehring as director.
Mark Moehring first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Moehring in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Moehring works with at each company, as listed on that company's latest Form D.
OtoNexus Medical Technologies, Inc. · Form D/A, Feb 15, 2024
MF
Marion Foote
Director
GG
George Gates
Executive officer and director
CC
Caitlin Cameron
President and Chief Executive Officer, director
HB
Harris Brody
Director